In this study, we demonstrated that the dual blockade of the VEGF-A/VEGFR2 pathway using anti-VEGFR2 and anti-VEGF-A antibodies significantly suppressed gastric tumor growth in a preclinical mouse model. This evidence concerns the gene VEGFA and gastric neoplasm.